FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126994142> ?p ?o ?g. }

• W3126994142 abstract "Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a convertase enzyme mostly produced by the liver. It is a key regulator of LDL metabolism because of its ability to enhance degradation of the LDL receptor. PCSK9 also regulates the metabolism of lipoprotein(a) [Lp(a)] and triglyceride-rich lipoproteins (TRLs). Its key role in modulating atherosclerotic cardiovascular disease (ASCVD) is supported by genetic studies and clinical outcome trials. Kinetic studies provide mechanistic insight into the role of PCSK9 in regulating the physiology and pathophysiology of plasma lipids and lipoproteins. Kinetic data have demonstrated that plasma PCSK9 concentration is inversely associated with the clearance of LDL in men. Gain-of-function mutations of PCSK9 markedly increase plasma LDL-cholesterol concentrations due to impaired LDL-apoB catabolism. Conversely, PCSK9 deficiency results in low LDL-cholesterol associated with enhanced LDL-apoB clearance. Inhibition of PCSK9 with monoclonal antibodies (such as evolocumab or alirocumab) lowers plasma LDL-cholesterol and apoB levels chiefly by upregulating the catabolism of LDL particles in healthy individuals. As monotherapy, PCSK9 inhibitor reduced Lp(a) concentrations by decreasing the production rate. However, as combination therapy, it reduced the plasma concentration of Lp(a) by increasing the fractional catabolism of Lp(a) particles. In statin-treated patients with high Lp(a), PCSK9 inhibition lowers plasma Lp(a) concentrations by accelerating the catabolism of Lp(a) particles. The effect of PCSK9 inhibition on TRL metabolism has been studied in healthy individuals and in patients with type 2 diabetes. These findings suggest that PCSK9 appears to play a less important role in TRL than LDL metabolism. Kinetic studies of PCSK9 inhibition therapy on lipoprotein metabolism in diverse high risk patient populations (such as familial hypercholesterolemia) and new therapeutic combination also merit further investigation." @default.
• W3126994142 created "2021-02-15" @default.
• W3126994142 creator A5008118241 @default.
• W3126994142 creator A5070816464 @default.
• W3126994142 creator A5063672280 @default.
• W3126994142 date "2021-02-10" @default.
• W3126994142 modified "2023-10-18" @default.
• W3126994142 title "New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects" @default.
• W3126994142 cites W1979390074 @default.
• W3126994142 cites W1991696239 @default.
• W3126994142 cites W2023283451 @default.
• W3126994142 cites W2028683797 @default.
• W3126994142 cites W2032630767 @default.
• W3126994142 cites W2040612932 @default.
• W3126994142 cites W2043461445 @default.
• W3126994142 cites W2045315353 @default.
• W3126994142 cites W2056411372 @default.
• W3126994142 cites W2058075760 @default.
• W3126994142 cites W2066511249 @default.
• W3126994142 cites W2067539811 @default.
• W3126994142 cites W2078669364 @default.
• W3126994142 cites W2080443045 @default.
• W3126994142 cites W2084744450 @default.
• W3126994142 cites W2086089950 @default.
• W3126994142 cites W2107513378 @default.
• W3126994142 cites W2119087485 @default.
• W3126994142 cites W2130626257 @default.
• W3126994142 cites W2140622082 @default.
• W3126994142 cites W2163720603 @default.
• W3126994142 cites W2166614932 @default.
• W3126994142 cites W2259605437 @default.
• W3126994142 cites W2316774118 @default.
• W3126994142 cites W2344763201 @default.
• W3126994142 cites W2404696858 @default.
• W3126994142 cites W2513186560 @default.
• W3126994142 cites W2560283770 @default.
• W3126994142 cites W2563852152 @default.
• W3126994142 cites W2596179513 @default.
• W3126994142 cites W2609543937 @default.
• W3126994142 cites W2731199601 @default.
• W3126994142 cites W2789891083 @default.
• W3126994142 cites W2802452781 @default.
• W3126994142 cites W2807265618 @default.
• W3126994142 cites W2807324205 @default.
• W3126994142 cites W2899997727 @default.
• W3126994142 cites W2914450987 @default.
• W3126994142 cites W2940327706 @default.
• W3126994142 cites W2954453953 @default.
• W3126994142 cites W2980989947 @default.
• W3126994142 cites W2996659077 @default.
• W3126994142 cites W2997944188 @default.
• W3126994142 cites W3000712048 @default.
• W3126994142 cites W3004951986 @default.
• W3126994142 cites W3014821231 @default.
• W3126994142 cites W3048679999 @default.
• W3126994142 cites W3183857127 @default.
• W3126994142 cites W65262745 @default.
• W3126994142 doi "https://doi.org/10.3389/fphys.2021.603910" @default.
• W3126994142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7902499" @default.
• W3126994142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33643062" @default.
• W3126994142 hasPublicationYear "2021" @default.
• W3126994142 type Work @default.
• W3126994142 sameAs 3126994142 @default.
• W3126994142 citedByCount "10" @default.
• W3126994142 countsByYear W31269941422021 @default.
• W3126994142 countsByYear W31269941422022 @default.
• W3126994142 countsByYear W31269941422023 @default.
• W3126994142 crossrefType "journal-article" @default.
• W3126994142 hasAuthorship W3126994142A5008118241 @default.
• W3126994142 hasAuthorship W3126994142A5063672280 @default.
• W3126994142 hasAuthorship W3126994142A5070816464 @default.
• W3126994142 hasBestOaLocation W31269941421 @default.
• W3126994142 hasConcept C126322002 @default.
• W3126994142 hasConcept C134018914 @default.
• W3126994142 hasConcept C185592680 @default.
• W3126994142 hasConcept C2778114629 @default.
• W3126994142 hasConcept C2778163477 @default.
• W3126994142 hasConcept C2778824825 @default.
• W3126994142 hasConcept C2778849439 @default.
• W3126994142 hasConcept C2780072125 @default.
• W3126994142 hasConcept C2780745583 @default.
• W3126994142 hasConcept C2780948078 @default.
• W3126994142 hasConcept C43554185 @default.
• W3126994142 hasConcept C62231903 @default.
• W3126994142 hasConcept C62746215 @default.
• W3126994142 hasConcept C71924100 @default.
• W3126994142 hasConcept C86803240 @default.
• W3126994142 hasConcept C96942376 @default.
• W3126994142 hasConceptScore W3126994142C126322002 @default.
• W3126994142 hasConceptScore W3126994142C134018914 @default.
• W3126994142 hasConceptScore W3126994142C185592680 @default.
• W3126994142 hasConceptScore W3126994142C2778114629 @default.
• W3126994142 hasConceptScore W3126994142C2778163477 @default.
• W3126994142 hasConceptScore W3126994142C2778824825 @default.
• W3126994142 hasConceptScore W3126994142C2778849439 @default.
• W3126994142 hasConceptScore W3126994142C2780072125 @default.
• W3126994142 hasConceptScore W3126994142C2780745583 @default.
• W3126994142 hasConceptScore W3126994142C2780948078 @default.
• W3126994142 hasConceptScore W3126994142C43554185 @default.
• W3126994142 hasConceptScore W3126994142C62231903 @default.

• next